- Home
- DAWN vs KIDS Comparison
DAWN vs KIDS Comparison
Compare DAWN & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- KIDS
- Stock Information
- Founded
- DAWN 2018
- KIDS 2007
- Country
- DAWN United States
- KIDS United States
- Employees
- DAWN N/A
- KIDS N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- KIDS Medical/Dental Instruments
- Sector
- DAWN Health Care
- KIDS Health Care
- Exchange
- DAWN Nasdaq
- KIDS Nasdaq
- Market Cap
- DAWN 658.9M
- KIDS 563.7M
- IPO Year
- DAWN 2021
- KIDS 2017
- Fundamental
- Price
- DAWN $6.71
- KIDS $20.72
- Analyst Decision
- DAWN Strong Buy
- KIDS Strong Buy
- Analyst Count
- DAWN 6
- KIDS 6
- Target Price
- DAWN $30.17
- KIDS $35.83
- AVG Volume (30 Days)
- DAWN 1.3M
- KIDS 147.1K
- Earning Date
- DAWN 08-05-2025
- KIDS 08-05-2025
- Dividend Yield
- DAWN N/A
- KIDS N/A
- EPS Growth
- DAWN N/A
- KIDS N/A
- EPS
- DAWN N/A
- KIDS N/A
- Revenue
- DAWN $161,922,000.00
- KIDS $212,453,000.00
- Revenue This Year
- DAWN $17.98
- KIDS $19.23
- Revenue Next Year
- DAWN $49.50
- KIDS $17.14
- P/E Ratio
- DAWN N/A
- KIDS N/A
- Revenue Growth
- DAWN N/A
- KIDS 31.28
- 52 Week Low
- DAWN $6.08
- KIDS $19.52
- 52 Week High
- DAWN $16.76
- KIDS $33.14
- Technical
- Relative Strength Index (RSI)
- DAWN 47.98
- KIDS 39.50
- Support Level
- DAWN $6.32
- KIDS $21.77
- Resistance Level
- DAWN $7.18
- KIDS $22.89
- Average True Range (ATR)
- DAWN 0.29
- KIDS 0.89
- MACD
- DAWN 0.01
- KIDS -0.17
- Stochastic Oscillator
- DAWN 36.11
- KIDS 1.32
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.